Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Urogen Pharma Ltd
NASDAQ:URGN
Urogen Pharma Ltd
NASDAQ:URGN
Price:
40.41
USD
-1.2%
Market Closed
Market Cap:
$2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Urogen Pharma Ltd
NASDAQ:URGN
|
IL |
|
S
|
Shimano Inc
SWB:SHM
|
JP |
|
PayPal Holdings Inc
BMV:PYPL
|
US |
|
O
|
Onto Innovation Inc
SWB:NNM
|
US |
|
Gear4music (Holdings) PLC
F:G4A
|
UK |
|
Amgen Inc
NASDAQ:AMGN
|
US |
|
Klepierre SA
PAR:LI
|
FR |
Wall St Price Targets
URGN Price Forecast
Based on 10 analysts
Based on 10 analysts
+49% Upside
from
$40.41
today
Urogen Pharma Ltd (URGN)’s 12-month stock price forecast through September 2027 has a consensus target of $60.18, implying 49% upside. The forecast is based on price targets from 10 Wall Street analysts.
URGN Analyst Rating
Based on 8 analysts
Based on 8 analysts
Analysts rate URGN Buy, with 6 of 8 recommending Buy or Strong buy.
Urogen Pharma Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is URGN's stock price target?
Price Target
60.18
USD
60.18
USD
According to Wall Street analysts, the average 1-year price target for URGN is 60.18 USD with a low forecast of 48.48 USD and a high forecast of 78.75 USD.
What is the Revenue forecast for Urogen Pharma Ltd?
Projected CAGR
31%
31%
The compound annual growth rate for Revenue over the next 8 years is 31%.
What is the Gross Profit forecast for Urogen Pharma Ltd?
Projected CAGR
31%
31%
The compound annual growth rate for Gross Profit over the next 8 years is 31%.